News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
124,803 Results
Type
Article (7340)
Company Profile (59)
Press Release (117404)
Multimedia
Podcasts (12)
Webinars (2)
Section
Business (38331)
Career Advice (88)
Deals (5947)
Drug Delivery (10)
Drug Development (23736)
Employer Resources (12)
FDA (3014)
Job Trends (3589)
News (68971)
Policy (4606)
Tag
2024 BioCapital Digital (1)
2024 BioForest Digital (1)
2024 BioMidwest Digital (1)
2024 Bio NC Digital (2)
2024 Biotech Bay Standard (1)
2024 Biotech Beach Standard (1)
2024 Genetown Standard (2)
2024 Pharm Country Standard (2)
2026 BioMidwest Elite (1)
2026 Biotech Bay Elite (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Pharm Country Elite (1)
2026 Pharm Country Standard (1)
Academia (325)
Accelerated approval (1)
Adcomms (10)
Allergies (3)
Alliances (11227)
ALS (9)
Alzheimer's disease (133)
Antibody-drug conjugate (ADC) (101)
Approvals (3055)
Artificial intelligence (81)
Autoimmune disease (3)
Automation (2)
Bankruptcy (55)
Best Places to Work (3319)
BIOSECURE Act (1)
Biosimilars (35)
Biotechnology (51)
Bladder cancer (62)
Brain cancer (22)
Breast cancer (201)
Cancer (1610)
Cardiovascular disease (17)
Career advice (76)
Career pathing (3)
CAR-T (70)
Cell therapy (160)
Cervical cancer (12)
Clinical research (19911)
Collaboration (335)
Compensation (104)
Complete response letters (1)
COVID-19 (313)
CRISPR (10)
C-suite (86)
Cystic fibrosis (1)
Data (752)
Decentralized trials (1)
Depression (5)
Diabetes (22)
Diagnostics (1317)
Digital health (3)
Diversity (1)
Diversity, equity & inclusion (5)
Drug discovery (44)
Drug pricing (10)
Drug shortages (1)
Duchenne muscular dystrophy (7)
Earnings (13117)
Editorial (9)
Employer branding (2)
Employer resources (13)
Events (23407)
Executive appointments (232)
FDA (3325)
Featured Employer (10)
Fibrodysplasia Ossificans Progressiva (1)
Frontotemporal dementia (1)
Funding (155)
Gene editing (18)
Generative AI (8)
Gene therapy (52)
GLP-1 (102)
Government (467)
Guidances (13)
Healthcare (4052)
Huntington's disease (2)
IgA nephropathy (5)
Immunology and inflammation (30)
Indications (14)
Infectious disease (333)
Inflammatory bowel disease (27)
Inflation Reduction Act (1)
Influenza (5)
Intellectual property (25)
Interviews (11)
IPO (2965)
IRA (7)
Job creations (483)
Job search strategy (69)
Kidney cancer (11)
Labor market (3)
Layoffs (126)
Leadership (3)
Legal (474)
Liver cancer (41)
Lung cancer (268)
Lymphoma (82)
Machine learning (2)
Management (3)
Manufacturing (44)
MASH (6)
Medical device (847)
Medtech (847)
Mergers & acquisitions (3115)
Metabolic disorders (61)
Multiple sclerosis (7)
NASH (1)
Neurodegenerative disease (6)
Neuropsychiatric disorders (1)
Neuroscience (206)
NextGen: Class of 2025 (953)
Non-profit (494)
Northern California (804)
Now hiring (7)
Obesity (32)
Opinion (31)
Ovarian cancer (58)
Pain (6)
Pancreatic cancer (53)
Parkinson's disease (20)
Partnered (1)
Patents (39)
Patient recruitment (30)
Peanut (2)
People (12954)
Pharmaceutical (14)
Pharmacy benefit managers (1)
Phase I (7512)
Phase II (8383)
Phase III (6397)
Pipeline (398)
Policy (17)
Postmarket research (472)
Preclinical (2361)
Press Release (2)
Prostate cancer (77)
Psychedelics (2)
Radiopharmaceuticals (163)
Rare diseases (59)
Real estate (735)
Recruiting (5)
Regulatory (4153)
Reports (8)
Research institute (663)
Resumes & cover letters (11)
RSV (8)
Schizophrenia (15)
Series A (34)
Series B (8)
Service/supplier (1)
Sickle cell disease (18)
Southern California (643)
Special edition (1)
Spinal muscular atrophy (16)
Sponsored (3)
Startups (752)
State (1)
Stomach cancer (10)
Supply chain (6)
Tariffs (4)
The Weekly (12)
United States (5799)
Vaccines (120)
Venture capitalists (13)
Weight loss (16)
Women's health (1)
Date
Today (47)
Last 7 days (285)
Last 30 days (775)
Last 365 days (8864)
2025 (2800)
2024 (9475)
2023 (10644)
2022 (13119)
2021 (13177)
2020 (10965)
2019 (8599)
2018 (6333)
2017 (7122)
2016 (6284)
2015 (6948)
2014 (4524)
2013 (3092)
2012 (3341)
2011 (3329)
2010 (3038)
Location
Africa (83)
Alabama (19)
Alaska (1)
Arizona (18)
Arkansas (2)
Asia (10722)
Australia (1436)
California (1658)
Canada (422)
China (276)
Colorado (50)
Connecticut (71)
Delaware (107)
Europe (19703)
Florida (210)
Georgia (8)
Idaho (6)
Illinois (158)
India (8)
Indiana (51)
Iowa (3)
Japan (71)
Kansas (8)
Kentucky (9)
Maine (3)
Maryland (212)
Massachusetts (1391)
Michigan (16)
Minnesota (64)
Missouri (6)
Montana (5)
Nebraska (2)
Nevada (8)
New Hampshire (7)
New Jersey (454)
New Mexico (3)
New York (405)
North Carolina (171)
Northern California (804)
Ohio (45)
Oklahoma (1)
Oregon (5)
Pennsylvania (263)
Rhode Island (4)
South America (112)
South Carolina (2)
Southern California (643)
Tennessee (15)
Texas (277)
Utah (42)
Virginia (15)
Washington D.C. (5)
Washington State (162)
Wisconsin (12)
124,803 Results for "loxo oncology".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Job Trends
Loxo@Lilly Announces Details of Presentations at 2023 European Hematology Association (EHA) Annual Meeting
Loxo@Lilly, the oncology unit of Eli Lilly and Company (NYSE: LLY), today announced that data from its oncology portfolio will be presented at the 2023 European Hematology Association (EHA) Annual Meeting, to be held June 8 – 11, 2023, in Frankfurt, Germany, and virtually.
May 11, 2023
·
12 min read
Press Releases
Gyre Therapeutics Announces NMPA Approval for Clinical Trial Evaluating Pirfenidone Capsules in Oncology-Related Pulmonary Complications
April 1, 2025
·
4 min read
Press Releases
Kura Oncology to Participate in Stifel Targeted Oncology Forum
April 1, 2025
·
2 min read
Press Releases
Pyxis Oncology to Participate in the Stifel 2025 Virtual Targeted Oncology Forum
April 2, 2025
·
1 min read
Cancer
The Search for the Next Keytruda: Immuno-Oncology’s Next Play
More than a decade after Merck’s Keytruda and BMS’ Yervoy ushered in the immuno-oncology revolution, the space is at a crossroads, with experts highlighting novel targets, combinations and pre-emptive immunization as the next wave for IO.
March 3, 2025
·
7 min read
·
Heather McKenzie
Deals
BridgeBio Oncology Takes Unexpected SPAC Track to Public Markets in $450M Deal
In a move straight out of 2021, BridgeBio Oncology is taking the SPAC route to the public markets in a deal with Helix Acquisition Corp. II worth $450 million in proceeds.
February 28, 2025
·
2 min read
·
Annalee Armstrong
Press Releases
Kura Oncology to Report First Quarter 2025 Financial Results
April 24, 2025
·
2 min read
Press Releases
Incyte to Showcase New Data from its Oncology Portfolio at 2025 American Society of Clinical Oncology (ASCO) Annual Meeting
April 24, 2025
·
7 min read
Press Releases
Advarra Unveils Oncology Research Pulse
March 12, 2025
·
3 min read
Job Trends
Loxo@Lilly Announces Details of Presentations at the 2022 American Society of Hematology Annual Meeting
Loxo@Lilly, the oncology unit of Eli Lilly and Company (NYSE: LLY), today announced that study investigators will present data from the BRUIN Phase 1/2 trial of pirtobrutinib at the American Society of Hematology (ASH) Annual Meeting to be held December 10-13, 2022, in New Orleans, Louisiana, and virtually.
November 3, 2022
·
6 min read
1 of 12,481
Next
